Transdiagnostic Individual Behavioral Activation and Exposure Therapy
Anxiety Disorders, Depression
About this trial
This is an interventional treatment trial for Anxiety Disorders focused on measuring Anxiety, Depression, Children, Adolescents, CBT
Eligibility Criteria
We expect 200 youth (ages 9-17 years) with either a principle anxiety (n=100) or a unipolar depression disorder (n=100) and their parents/caregivers to serve as participants.
Inclusion Criteria:
To participate, a youth must meet criteria for a primary DSM-5 (American Psychiatric Association, 2003) diagnosis of any of the following:
- Generalized Anxiety Disorder (GAD)
- Separation Anxiety Disorder (SEP)
- Social Anxiety Disorder (SAD)
- Specific Phobia (SP)
- Panic Disorder (PD)
- Agoraphobia
- Major Depression Disorder (MDD)
- Depression Disorder - Insufficient Symptoms (DD-Insufficient)
- Persistent Depressive Disorder (PDD)
Comorbid (non-principal) disorders are acceptable, including the presence of disorders not listed above. Diagnosis will be based on both youth and parent report during an Independent Evaluator (IE) semi-structured interview. Youth may also participate with a subclinical diagnosis for any of these disorders if: (a) the youth demonstrates sufficient symptoms but does not yet reach clinical levels of impairment OR (b) the youth demonstrates only several symptoms related to the above disorders but demonstrates clinical impairment, AND (c) the consenting parent agrees that anxiety or mood problems would be appropriate as a clinical focus for treatment. Allowing youth with subclinical diagnoses will allow the study to investigate the effectiveness of the therapies across a range of clinical severity. This design models usual community care where a larger range of severity is witnessed and many youth may not meet all criteria for formal diagnosis. After receiving an initial diagnostic assessment at T1, the parent must consent and the youth must assent to continued participation in the study, including randomization to treatment condition, and must be willing to receive psychological therapy at the Youth Anxiety and Depression Clinic (YAD-C), a specialty program within the outpatient clinic of the Rutgers University Graduate School of Applied and Professional Psychology (GSAPP).
Exclusion Criteria:
Youth who have a principal DSM-5 disorder other than one of the above listed anxiety or depression disorders (e.g., anorexia nervosa, Post-traumatic Stress Disorder, Attention Deficit-Hyperactivity Disorder), or who have received any diagnosis of:
- Intellectual Disability
- Autism Spectrum Disorder
- schizophrenia
- bipolar disorder.
Youth who demonstrate suicidal ideation or intent (by child or parent report) severe enough to require current hospitalization, or youth who have attempted suicide in the past 3 months, will also be excluded. These clinical problems require specialized treatment that YAD-C is not prepared to offer. Youth will not be excluded on the basis of gender or racial/ethnic origin. However, youth and at least one parent will be required to speak English sufficiently enough to complete study procedures and surveys in English. Participants will be asked not to engage in any other outpatient psychological treatment during their time in the study; this is important to enhance internal validity of the study and conforms with best clinical practices to avoid conflicting treatment recommendations. However, current use of antidepressant or anxiolytic medications will NOT be an exclusion. Participants will be asked to arrive at a stable dosage and schedule for their medication, in consultation with their presiding physician or psychiatrist, prior to study initiation. Use of medications and any other treatment modalities will be assessed during study participation and compared across treatment and WL conditions.
Sites / Locations
- Youth Anxiety and Depression ClinicRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
Principal Anxiety Disorder
Principal Depressive Disorder
Youth with a principal anxiety disorder
Youth with a principal unipolar depressive disorder